INZY
Price
$5.83
Change
-$0.00 (-0.00%)
Updated
Sep 17 closing price
48 days until earnings call
PLRX
Price
$12.60
Change
-$0.00 (-0.00%)
Updated
Sep 17 closing price
48 days until earnings call
Ad is loading...

INZY vs PLRX

Header iconINZY vs PLRX Comparison
Open Charts INZY vs PLRXBanner chart's image
Inozyme Pharma
Price$5.83
Change-$0.00 (-0.00%)
Volume$195.96K
CapitalizationN/A
Pliant Therapeutics
Price$12.60
Change-$0.00 (-0.00%)
Volume$691.57K
CapitalizationN/A
View a ticker or compare two or three
INZY vs PLRX Comparison Chart
Loading...
INZY
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
PLRX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VS
INZY vs. PLRX commentary
Sep 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is INZY is a Buy and PLRX is a Hold.

COMPARISON
Comparison
Sep 19, 2024
Stock price -- (INZY: $5.83 vs. PLRX: $12.60)
Brand notoriety: INZY and PLRX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: INZY: 71% vs. PLRX: 160%
Market capitalization -- INZY: $391.19M vs. PLRX: $766.1M
INZY [@Biotechnology] is valued at $391.19M. PLRX’s [@Biotechnology] market capitalization is $766.1M. The market cap for tickers in the [@Biotechnology] industry ranges from $609.91B to $0. The average market capitalization across the [@Biotechnology] industry is $3.05B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

INZY’s FA Score shows that 0 FA rating(s) are green whilePLRX’s FA Score has 0 green FA rating(s).

  • INZY’s FA Score: 0 green, 5 red.
  • PLRX’s FA Score: 0 green, 5 red.
According to our system of comparison, INZY is a better buy in the long-term than PLRX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

INZY’s TA Score shows that 6 TA indicator(s) are bullish while PLRX’s TA Score has 3 bullish TA indicator(s).

  • INZY’s TA Score: 6 bullish, 4 bearish.
  • PLRX’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, INZY is a better buy in the short-term than PLRX.

Price Growth

INZY (@Biotechnology) experienced а +10.84% price change this week, while PLRX (@Biotechnology) price change was -2.93% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.17%. For the same industry, the average monthly price growth was +1.67%, and the average quarterly price growth was -2.02%.

Reported Earning Dates

INZY is expected to report earnings on Nov 05, 2024.

PLRX is expected to report earnings on Nov 05, 2024.

Industries' Descriptions

@Biotechnology (+1.17% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PLRX($766M) has a higher market cap than INZY($391M). INZY YTD gains are higher at: 36.854 vs. PLRX (-30.425). INZY has higher annual earnings (EBITDA): -82.82M vs. PLRX (-181.41M). PLRX has more cash in the bank: 437M vs. INZY (145M). INZY has less debt than PLRX: INZY (46.7M) vs PLRX (60.2M). INZY (0) and PLRX (0) have equivalent revenues.
INZYPLRXINZY / PLRX
Capitalization391M766M51%
EBITDA-82.82M-181.41M46%
Gain YTD36.854-30.425-121%
P/E RatioN/AN/A-
Revenue00-
Total Cash145M437M33%
Total Debt46.7M60.2M78%
TECHNICAL ANALYSIS
Technical Analysis
INZYPLRX
RSI
ODDS (%)
Bearish Trend 2 days ago
85%
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
79%
Momentum
ODDS (%)
Bullish Trend 2 days ago
88%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
89%
Bearish Trend 2 days ago
87%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
87%
Bullish Trend 2 days ago
75%
Advances
ODDS (%)
Bullish Trend 6 days ago
87%
Bullish Trend 14 days ago
78%
Declines
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 7 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
76%
Aroon
ODDS (%)
Bullish Trend 2 days ago
85%
N/A
View a ticker or compare two or three
Ad is loading...
INZY
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
PLRX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
NRGSX67.250.51
+0.76%
Neuberger Berman Genesis R6
GTSDX8.940.05
+0.56%
Invesco Small Cap Growth C
BRXUX13.950.03
+0.22%
MFS Blended Research Intl Eq R4
MIMFX13.20N/A
N/A
AMG Veritas China I
MAICX8.41-0.02
-0.24%
Victory Trivalent Intl Fd-Core Eq A

INZY and

Correlation & Price change

A.I.dvisor indicates that over the last year, INZY has been loosely correlated with BEAM. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if INZY jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INZY
1D Price
Change %
INZY100%
-2.67%
BEAM - INZY
58%
Loosely correlated
-0.16%
NTLA - INZY
54%
Loosely correlated
+4.83%
DNLI - INZY
50%
Loosely correlated
+1.15%
PLRX - INZY
49%
Loosely correlated
+6.15%
SEER - INZY
49%
Loosely correlated
+2.38%
More